Navigation Links
Pharmaceutical Pricing and Reimbursement in Oncology - Payer Pressure to Justify Premium Pricing of Novel Agents, Pushing Companies to Risk-Sharing Modalities
Date:7/17/2012

eimbursement in Oncology, Change in Premiums, Japan, 2002-2008 57Table 15: Pricing and Reimbursement in Oncology, List of Drugs Introduced to NHI, Japan, 2011 59

List of Figures

1.2 List of FiguresFigure 1: Pricing and Reimbursement in Oncology, Diseased Population in the Top Seven Countries for Major Types of Cancer (millions), 2010 9Figure 2: Pricing and Reimbursement in Oncology, Age Standardized Cancer Incidence, Top Seven Countries, 2008 10Figure 3: Pricing and Reimbursement in Oncology, Age Standardized Cancer Mortality, Top Seven Countries, 2008 11Figure 4: Pricing and Reimbursement in Oncology, the US, Total Healthcare Expenditure vs. Out-of-Pocket Expenditure (%), 2009 17Figure 5: Pricing and Reimbursement in Oncology, the US, Expenditure for Cancer Care ($bn), 2010 and 2020 19Figure 6: Pricing and Reimbursement in Oncology, the US, Expenditure for Cancer Care in the Top Five Indications ($bn), 2010 and 2020 20Figure 7: Pricing and Reimbursement in Oncology, the US, Estimated Cancer Cases, By Sites, Men (%), 2011 22Figure 8: Pricing and Reimbursement in Oncology, the US, Estimated Cancer Cases, By Sites, Women (%), 2011 23Figure 9: Pricing and Reimbursement in Oncology, Total Per-capita Expenditure on Pharmaceuticals, Top Five Countries of Europe and the US, $PPP, 1990-2009 27Figure 10: Pricing and Reimbursement in Oncology, NHS and Private Composition of Pharmaceutical Expenditure, Italy, %, 2009 28Figure 11: Pricing and Reimbursement in Oncology, Public Pharmaceutical Expenditure, Pharmacies, Growth Rates (%), 2010-2011 32Figure 12: Pricing and Reimbursement in Oncology, Germany, Healthcare Expenditure by Financing Agent, $ per inhabitant, 2007, 2008, 2009 34Figure 13: Pricing and Reimbursement in Oncology, Germany, Structural Reforms by AMNOG, 2011 37Figure 14: Pricing and Reimbursement in Oncology, European Counties, the US and Japan, Total Healthcare Expenditure vs. Out-of-Pocket Expenditure, 2009 39Figure 15: Pricing and Reimbursement in
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Direct to Consumer (DTC) Advertising in Pharmaceuticals - Shift from Traditional Mass-Media Platforms towards Personalization via Online and Social Media
2. Valeant Pharmaceuticals To Announce 2012 Second Quarter Results On August 2, 2012
3. Par Pharmaceutical Companies, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By TPG
4. 81,200 Square Foot Lease Extension In San Diego Through 2018 Signed By Vertex Pharmaceuticals And BioMed Realty
5. Anthera Pharmaceuticals Provides Additional Data from the Recently Completed PEARL-SC Study of Blisibimod in the Proposed Phase 3 Population
6. Ampio Pharmaceuticals Announces Exercise of Over-Allotment Option
7. Par Formulations (Formerly Edict Pharmaceuticals) Receives First ANDA Approval
8. ResearchMoz.US: Direct to Consumer (DTC) Advertising in Pharmaceuticals - Shift From Traditional Mass-Media Platforms Towards Personalization via Online and Social Media- Market Research Report
9. Ampio Pharmaceuticals Announces Pricing of Public Offering of 4,615,400 Shares of Common Stock
10. Early Birds Save Up to $600 on Asian Biotech and Pharmaceutical Conferences
11. Ampio Pharmaceuticals Announces Proposed Public Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... Jan. 23, 2015  A new analysis of Centers for ... enrollment data shows that 81 percent of seniors chose ... extra discounts at certain pharmacies. The findings were released ... plans are now the foundation of Medicare Part D," ...
(Date:1/23/2015)... DUBLIN , Jan. 23, 2015  Immune Therapeutics, Inc. today ... Inc. for the compounding, packaging and distributing of its naltrexone ... the United States . KRS ... compounding naltrexone tablets in various strengths for individual patients in ...
(Date:1/23/2015)... 23, 2015  Now available for sale, The Armor1 Ankle ... prevents ankle sprains by cushioning the ankle from an ... around the outside of any shoe type and allows ... still offering protection against sprains. With customers in physical ...
Breaking Medicine Technology:New Analysis: 81 Percent of Medicare Part D Seniors Choose "Preferred Pharmacy" Plans in 2015 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 4The Armor1 Ankle Roll Guard is the New Breakthrough Solution for Ankle Sprain Prevention! 2
... Holdings, Inc. (OTC Bulletin Board: ADLS ), announced ... discussing the Company,s 2010 third quarter financial results on Friday, ... Ph.D., Chairman & Chief Executive Officer, as well as other ... on the Company. A press release reporting the 2010 third ...
... 2010 Neuraltus Pharmaceuticals, a privately held biopharmaceutical ... that address critical unmet needs, primarily in the ... was awarded three grants totaling $733,437 ... (QTDP).  The grants are being provided under section ...
Cached Medicine Technology:Advanced Life Sciences to Host 2010 Third Quarter Financial Results Conference Call and Webcast 2Neuraltus Pharmaceuticals Awarded $733,437 Under the Qualifying Therapeutic Discovery Projects Grant Program (QTDP) 2Neuraltus Pharmaceuticals Awarded $733,437 Under the Qualifying Therapeutic Discovery Projects Grant Program (QTDP) 3
(Date:1/22/2015)... Gabe’s Chemo Duck Program is pleased to announce the release of ... kids with cancer. The Chemo Duck App, available on iTunes for ... games to help children of all ages living with cancer adjust ... kids entertained, educated and at ease while waiting for clinic visits ...
(Date:1/22/2015)... 2015 Blue Cross and Blue Shield of ... what it means to “Live Fearless.” , The ... share their stories about how they or someone they know ... by living in the moment. By telling these types of ...
(Date:1/22/2015)... 2015 Thousand of GranuFlo lawsuits ( ... its GranuFlo and NaturaLyte dialysis concentrates continue to move ... District Court, District of Massachusetts, Bernstein Liebhard LLP reports. ... has remanded a case filed by the state of ...
(Date:1/22/2015)... York, NY (PRWEB) January 22, 2015 ... College of Sports Medicine flagship journal Medicine & ... with L-Citrulline before exercise may help reduce gastrointestinal ... exercise. 1 , Participants in the double-blind, ...
(Date:1/22/2015)... 2015 Payday lending practices in four ... cause financial distress to the states that permit them, ... University’s Center on Race and Wealth. , While they ... payday loans at the same time substantially depress economic ...
Breaking Medicine News(10 mins):Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2
... Beauty Broadcast Benefits the Breast Cancer Research Fund, ... to be,tickled pink this May when leading multimedia retailer ... 27 at 1 AM (ET) and 6 PM,(ET). These ... with a portion of the proceeds benefiting the Breast ...
... speech June 9 in Atlanta, DENVER, May 21 ... Disease Control and Prevention (CDC), will,discuss water professionals, role ... American Water Works Association,s Annual Conference,& Exposition (ACE08) at ... one of the leading public health experts in the ...
... HILL, N.C., May 21 In this ... increasingly,complex organizational and decision-making structures to effectively,represent ... it onto hospital,formularies., Best Practices, LLC,s ... Effectiveness" (available at, http://www.best-in-class.com/cr208.htm ) addresses ...
... in Three of the Last Four ... ... PER ) and Harvard Pilgrim Health Care were named by the,Outsourcing ... by the Everest Group and Forbes,magazine, these awards honor the most outstanding ...
... Two outstanding members of the Worcester Polytechnic Institute ... during the universitys 140th Commencement exercises on May 17, ... Donald K. Peterson 71, chair of the WPI Board ... Inc., the prize honors WPI faculty members for overall ...
... than those having kidney replacement alone , , WEDNESDAY, ... alone, a simultaneous kidney-pancreas transplant improves the likelihood of ... end-stage renal disease (ESRD), according to a German study. ... more than 11,000 patients with type 1 diabetes and ...
Cached Medicine News:Health News:A Touch of Pink Never Looked So Good 2Health News:CDC Director to Address Public Health and Drinking Water at ACE08 2Health News:Harvard Pilgrim Health Care and Perot Systems Named as 'Best Partnership' by Outsourcing Center 2Health News:Harvard Pilgrim Health Care and Perot Systems Named as 'Best Partnership' by Outsourcing Center 3Health News:Harvard Pilgrim Health Care and Perot Systems Named as 'Best Partnership' by Outsourcing Center 4Health News:Harvard Pilgrim Health Care and Perot Systems Named as 'Best Partnership' by Outsourcing Center 5Health News:Worcester Polytechnic Institute announces 2008 Chairman's Exemplary Faculty Prize winners 2Health News:Worcester Polytechnic Institute announces 2008 Chairman's Exemplary Faculty Prize winners 3Health News:Combo Kidney-Pancreas Transplant Boosts Survival in Diabetics 2
For the quantitative determination of total cholesterol in serum....
For the quantitative determination of total cholesterol in human serum....
Intended for the quantitative determination of total cholesterol in serum. Single vial, dry powder reagent. Reaction: Endpoint. Wavelength: 500 nm. Linearity: 700 mg/dL (12.9 mmol/L)....
For the quantitative in vitro determination of lithium in serum and plasma. Wavelength: 550 nm. Linear range: up to 4 mm....
Medicine Products: